SCHEMBL30770352

SCHEMBL30770352

[2H]c1nc2cncnc2s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165271 0.77
SCHEMBL29504479 0.77
Urea SCHEMBL1760920 0.68 PI4KA (0.36)
Piperazine SCHEMBL798274 0.68 PI4KA (0.32)
SCHEMBL31119774 0.67 KDM4E (0.31)
SCHEMBL31049795 0.67
Acetamide SCHEMBL9933914 0.66 PI4KA (0.34)
SCHEMBL28957900 0.66 PI4KA (0.31)
SCHEMBL35212535 0.65
SCHEMBL655393 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240336628-A1 NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF BREAKPOINT THERAPEUTICS GMBH (DE) 2024-10-10 US disclosed
CN-115427412-B Nitrogen-containing fused ring derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-02-20 CN disclosed